Publicaciones (23) Publicaciones en las que ha participado algún/a investigador/a

2005

  1. Amplification of IGH/MYC fusion in clinically aggressive IGH/BCL2-positive germinal center B-cell lymphomas

    Genes Chromosomes and Cancer, Vol. 43, Núm. 4, pp. 414-423

  2. Anticoagulant treatment and survival in cancer patients. The evidence from clinical studies

    Haematologica, Vol. 90, Núm. 9, pp. 1258-1266

  3. BCR-ABL induces the expression of Skp2 through the PI3K pathway to promote p27Kip1 degradation and proliferation of chronic myelogenous leukemia cells

    Cancer Research, Vol. 65, Núm. 8, pp. 3264-3272

  4. Coexistence of different clonal populations harboring the b3a2 (p210) and e1a2 (p190) BCR-ABL1 fusion transcripts in chronic myelogenous leukemia resistant to imatinib

    Cancer Genetics and Cytogenetics, Vol. 160, Núm. 1, pp. 22-26

  5. Fibrinógeno. Vieja proteína hemostática con nueva función: Marcador no invasivo de aterosclerosis subclínica

    Medicina Clinica, Vol. 124, Núm. 20, pp. 790-794

  6. IFN-α gene therapy for woodchuck hepatitis with adeno-associated virus: Differences in duration of gene expression and antiviral activity using intraportal or intramuscular routes

    Molecular Therapy, Vol. 12, Núm. 1, pp. 68-76

  7. Independent association of von Willebrand factor with surrogate markers of atherosclerosis in middle-aged asymptomatic subjects

    Journal of Thrombosis and Haemostasis, Vol. 3, Núm. 4, pp. 662-664

  8. Induction of gp120-specific protective immune responses by genetic vaccination with linear polyethylenimine-plasmid complex

    Vaccine, Vol. 23, Núm. 11, pp. 1384-1392

  9. Lack of CpG island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis

    Journal of Clinical Oncology, Vol. 23, Núm. 28, pp. 7043-7049

  10. Medicina regenerativa con células madre adultas

    Revista Clinica Espanola, Vol. 205, Núm. 11, pp. 556-564

  11. Metaloproteasas en aterosclerosis: implicaciones fisiopatológicas y terapéuticas

    Clínica e investigación en arteriosclerosis, Vol. 17, Núm. 3, pp. 133-141

  12. Monocyte cyclooxygenase-2 activity: A new therapeutic target for atherosclerosis?

    Current Drug Targets - Cardiovascular and Haematological Disorders, Vol. 5, Núm. 4, pp. 303-311

  13. Monocyte cyclooxygenase-2 overactivity: A new marker of subclinical atherosclerosis in asymptomatic subjects with cardiovascular risk factors?

    European Heart Journal, Vol. 26, Núm. 2, pp. 153-158

  14. Myocardial regeneration: future at reach

    Revista de medicina de la Universidad de Navarra, Vol. 49, Núm. 3, pp. 62-68

  15. NUP98 is fused to HOXA9 in a variant complex t(7;11;13;17) in a patient with AML-M2

    Cancer Genetics and Cytogenetics, Vol. 157, Núm. 2, pp. 151-156

  16. New strategies in the secondary prevention of relapsing venous thromboembolism

    Medicina Clinica, Vol. 125, Núm. 19, pp. 748-755

  17. Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapse

    Annals of Oncology, Vol. 16, Núm. 4, pp. 625-633

  18. Promoter hypomethylation of the LINE-1 retrotransposable elements activates sense/antisense transcription and marks the progression of chronic myeloid leukemia

    Oncogene, Vol. 24, Núm. 48, pp. 7213-7223

  19. Reducción de las necesidades transfusionales en hemorragias adquiridas graves mediante factor VII activo recombinante

    Medicina Clinica, Vol. 125, Núm. 7, pp. 252-253

  20. Trasplante celular y terapia regenerativa con células madre

    SIBI: Revista de la Sociedad Internacional de Bioética = Journal of the International Society of Bioethics = Revue de la Societé Internationale de la Bioéthique, Núm. 14, pp. 16-31